Wnt16 Attenuates TGFβ-Induced Chondrogenic Transformation in Vascular Smooth Muscle

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 35, Issue 3, 2015, Pages 573-579

  Beazley, Kelly E ^a   Nurminsky, Dmitry ^a   Lima, Florence ^a   Gandhi, Chintan ^a   Nurminskaya, Maria V ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Chondrogenesis; Mouse; Muscle; Notch protein; Smooth; TGF beta; Vascular; Vascular calcification; Wnt16 protein

Indexed keywords

NOTCH RECEPTOR; OSTEOCALCIN; PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT16 PROTEIN; CALCIUM BINDING PROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN; TGFB1 PROTEIN, MOUSE; TGFB3 PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; WNT PROTEIN; WNT16 PROTEIN, HUMAN; WNT16 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; ATTENUATION; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; DOWN REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; AORTA; BLOOD VESSEL CALCIFICATION; C57BL MOUSE; CELL TRANSDIFFERENTIATION; CHLOROCEBUS AETHIOPS; CHONDROCYTE; COS CELL LINE; DEFICIENCY; GENETIC TRANSFECTION; GENETICS; KNOCKOUT MOUSE; METABOLISM; METAPLASIA; PATHOLOGY; PHENOTYPE; RAT; RNA INTERFERENCE; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; CALCIUM-BINDING PROTEINS; CELL TRANSDIFFERENTIATION; CERCOPITHECUS AETHIOPS; CHONDROCYTES; CHONDROGENESIS; COS CELLS; EXTRACELLULAR MATRIX PROTEINS; METAPLASIA; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHENOTYPE; RATS; RECEPTORS, NOTCH; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VASCULAR CALCIFICATION; WNT PROTEINS;

EID: 84921829325     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.114.304393     Document Type: Article

References (48)

1. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004;286:E686-E696. doi: 10.1152/ajpendo.00552.2003.
2. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386:78-81. doi: 10.1038/386078a0.
3. Murshed M, Schinke T, McKee MD, Karsenty G. Extracellular matrix mineralization is regulated locally; different roles of two GLA-containing proteins. J Cell Biol. 2004;165:625-630. doi: 10.1083/jcb.200402046.
4. Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet. 1999;21:142-144. doi: 10.1038/5102.
5. Herrmann SM, Whatling C, Brand E, Nicaud V, Gariepy J, Simon A, Evans A, Ruidavets JB, Arveiler D, Luc G, Tiret L, Henney A, Cambien F. Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol. 2000;20:2386-2393.
6. Boström KI, Rajamannan NM, Towler DA. The regulation of valvular and vascular sclerosis by osteogenic morphogens. Circ Res. 2011;109:564-577. doi: 10.1161/CIRCRESAHA.110.234278.
7. Beazley KE, Deasey S, Lima F, Nurminskaya MV. Transglutaminase 2-mediated activation of beta-catenin signaling has a critical role in warfarin-induced vascular calcification. Arterioscler Thromb Vasc Biol. 2012;32:123-130.
8. Shimizu T, Tanaka T, Iso T, Matsui H, Ooyama Y, Kawai-Kowase K, Arai M, Kurabayashi M. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J Biol Chem. 2011;286:19138-19148. doi: 10.1074/jbc.M110.175786.
9. Long F. Targeting intercellular signals for bone regeneration from bone marrow mesenchymal progenitors. Cell Cycle. 2008;7:2106-2111.
10. Andersson ER, Sandberg R, Lendahl U. Notch signaling: simplicity in design, versatility in function. Development. 2011;138:3593-3612. doi: 10.1242/dev.063610.
11. Grainger DJ, Metcalfe JC, Grace AA, Mosedale DE. Transforming growth factor-beta dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci. 1998;111 (pt 19):2977-2988.
12. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol. 2006;26:1423-1430. doi: 10.1161/01.ATV.0000220441.42041.20.
13. Mathew S, Davies M, Lund R, Saab G, Hruska KA. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease. Eur J Clin Invest. 2006;36(suppl 2):43-50. doi: 10.1111/j.1365-2362.2006.01663.x.
14. Mikhaylova L, Malmquist J, Nurminskaya M. Regulation of in vitro vascular calcification by BMP4, VEGF and Wnt3a. Calcif Tissue Int. 2007;81:372-381. doi: 10.1007/s00223-007-9073-6.
15. Caira FC, Stock SR, Gleason TG, McGee EC, Huang J, Bonow RO, Spelsberg TC, McCarthy PM, Rahimtoola SH, Rajamannan NM. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol. 2006;47:1707-1712. doi: 10.1016/j.jacc.2006.02.040.
16. Beazley KE, Banyard D, Lima F, Deasey SC, Nurminsky DI, Konoplyannikov M, Nurminskaya MV. Transglutaminase inhibitors attenuate vascular calcification in a preclinical model. Arterioscler Thromb Vasc Biol. 2013;33:43-51. doi: 10.1161/ATVBAHA.112.300260.
17. Beazley KE, Lima F, Borras T, Nurminskaya M. Attenuation of chondrogenic transformation in vascular smooth muscle by dietary quercetin in the MGP-deficient mouse model. PLoS One. 2013;8:e76210. doi: 10.1371/ journal.pone.0076210.
18. Cheng SL, Shao JS, Behrmann A, Krchma K, Towler DA. Dkk1 and MSX2-Wnt7b signaling reciprocally regulate the endothelial-mesenchymal transition in aortic endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33:1679-1689. doi: 10.1161/ATVBAHA.113.300647.
19. Fouillade C, Monet-Leprêtre M, Baron-Menguy C, Joutel A. Notch signalling in smooth muscle cells during development and disease. Cardiovasc Res. 2012;95:138-146. doi: 10.1093/cvr/cvs019.
20. Watanabe N, Tezuka Y, Matsuno K, Miyatani S, Morimura N, Yasuda M, Fujimaki R, Kuroda K, Hiraki Y, Hozumi N, Tezuka K. Suppression of differentiation and proliferation of early chondrogenic cells by Notch. J Bone Miner Metab. 2003;21:344-352. doi: 10.1007/s00774-003-0428-4.
21. Shimizu T, Tanaka T, Iso T, Doi H, Sato H, Kawai-Kowase K, Arai M, Kurabayashi M. Notch signaling induces osteogenic differentiation and mineralization of vascular smooth muscle cells: role of Msx2 gene induction via Notch-RBP-Jk signaling. Arterioscler Thromb Vasc Biol. 2009;29:1104-1111. doi: 10.1161/ATVBAHA.109.187856.
22. Nigam V, Srivastava D. Notch1 represses osteogenic pathways in aortic valve cells. J Mol Cell Cardiol. 2009;47:828-834. doi: 10.1016/j. yjmcc.2009.08.008.
23. Witte F, Dokas J, Neuendorf F, Mundlos S, Stricker S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr Patterns. 2009;9:215-223. doi: 10.1016/j.gep.2008.12.009.
24. Guo X, Day TF, Jiang X, Garrett-Beal L, Topol L, Yang Y. Wnt/betacatenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 2004;18:2404-2417. doi: 10.1101/gad.1230704.
25. Kronenberg HM. The role of the perichondrium in fetal bone development. Ann N Y Acad Sci. 2007;1116:59-64. doi: 10.1196/annals.1402.059.
26. Hendrickx G, Boudin E, Fija?kowski I, Nielsen TL, Andersen M, Brixen K, Van Hul W. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters. Bone. 2014;59:57-65. doi: 10.1016/j.bone.2013.10.022.
27. Clements WK, Kim AD, Ong KG, Moore JC, Lawson ND, Traver D. A somitic Wnt16/Notch pathway specifies haematopoietic stem cells. Nature. 2011;474:220-224. doi: 10.1038/nature10107.
28. Speer MY, Li X, Hiremath PG, Giachelli CM. Runx2/Cbfa1, but not loss of myocardin, is required for smooth muscle cell lineage reprogramming toward osteochondrogenesis. J Cell Biochem. 2010;110:935-947. doi: 10.1002/jcb.22607.
29. Beazley KE, Reckard S, Nurminsky D, Lima F, Nurminskaya M. Two sides of MGP null arterial disease: chondrogenic lesions dependent on transglutaminase 2 and elastin fragmentation associated with induction of adipsin. J Biol Chem. 2013;288:31400-31408. doi: 10.1074/jbc. M113.495556.
30. Denker AE, Nicoll SB, Tuan RS. Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1. Differentiation. 1995;59:25-34. doi: 10.1046/j.1432-0436.1995.5910025.x.
31. Molin DGM, DeRuiter MC, Doetschamn T, Suciv HM, Poelmann RE, Gittehnerger-de Groot A. TGFb2 does not affect neural creast cell migration but is a key player in vascular remodeling during embryogenesis. In: Artman MD, Benson W, Srivastava, D., Nakazawa M, eds. Cardiovascular Development and Congenital Malformations: Molecular & Genetic Mechanisms. 1 ed. John Wiley and Sons; 2008:148-150.
32. Inman GJ, Nicolás FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptorlike kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65-74.
33. Dituri F, Mazzocca A, Peidrò FJ, Papappicco P, Fabregat I, De Santis F, Paradiso A, Sabbà C, Giannelli G. Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. PLoS One. 2013;8:e67109. doi: 10.1371/journal.pone.0067109.
34. Fujimaki R, Toyama Y, Hozumi N, Tezuka K. Involvement of Notch signaling in initiation of prechondrogenic condensation and nodule formation in limb bud micromass cultures. J Bone Miner Metab. 2006;24:191-198. doi: 10.1007/s00774-005-0671-y.
35. Neven E, Persy V, Dauwe S, De Schutter T, De Broe ME, D'Haese PC. Chondrocyte rather than osteoblast conversion of vascular cells underlies medial calcification in uremic rats. Arterioscler Thromb Vasc Biol. 2010;30:1741-1750. doi: 10.1161/ATVBAHA.110.204834.
36. Nakagawa Y, Ikeda K, Akakabe Y, Koide M, Uraoka M, Yutaka KT, Kurimoto-Nakano R, Takahashi T, Matoba S, Yamada H, Okigaki M, Matsubara H. Paracrine osteogenic signals via bone morphogenetic protein-2 accelerate the atherosclerotic intimal calcification in vivo. Arterioscler Thromb Vasc Biol. 2010;30:1908-1915. doi: 10.1161/ ATVBAHA.110.206185.
37. Miriyala S, Gongora Nieto MC, Mingone C, Smith D, Dikalov S, Harrison DG, Jo H. Bone morphogenic protein-4 induces hypertension in mice: role of noggin, vascular NADPH oxidases, and impaired vasorelaxation. Circulation. 2006;113:2818-2825. doi: 10.1161/ CIRCULATIONAHA.106.611822.
38. Sanford LP, Ormsby I, Gittenberger-de Groot AC, Sariola H, Friedman R, Boivin GP, Cardell EL, Doetschman T. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development. 1997;124:2659-2670.
39. Kurpinski K, Lam H, Chu J, Wang A, Kim A, Tsay E, Agrawal S, Schaffer DV, Li S. Transforming growth factor-beta and notch signaling mediate stem cell differentiation into smooth muscle cells. Stem Cells. 2010;28:734-742. doi: 10.1002/stem.319.
40. Teh MT, Blaydon D, Ghali LR, Briggs V, Edmunds S, Pantazi E, Barnes MR, Leigh IM, Kelsell DP, Philpott MP. Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci. 2007;120(pt 2):330-339. doi: 10.1242/jcs.03329.
41. Binet R, Ythier D, Robles AI, Collado M, Larrieu D, Fonti C, Brambilla E, Brambilla C, Serrano M, Harris CC, Pedeux R. WNT16B is a new marker of cellular senescence that regulates p53 activity and the phosphoinositide 3-kinase/AKT pathway. Cancer Res. 2009;69:9183-9191. doi: 10.1158/0008-5472.CAN-09-1016.
42. Doyle AJ, Redmond EM, Gillespie DL, Knight PA, Cullen JP, Cahill PA, Morrow DJ. Differential expression of Hedgehog/Notch and transforming growth factor-beta in human abdominal aortic aneurysms. J Vasc Surg 2014;(14):10.
43. Yao Y, Yao J, Radparvar M, Blazquez-Medela AM, Guihard PJ, Jumabay M, Boström KI. Reducing Jagged 1 and 2 levels prevents cerebral arteriovenous malformations in matrix Gla protein deficiency. Proc Natl Acad Sci U S A. 2013;110:19071-19076. doi: 10.1073/pnas.1310905110.
44. Medina-Gomez C, Kemp JP, Estrada K, et al. Meta-analysis of genomewide scans for total body BMD in children and adults reveals allelic heterogeneity and age-specific effects at the WNT16 locus. PLoS Genet. 2012;8:e1002718. doi: 10.1371/journal.pgen.1002718.
45. Corrigan PM, Dobbin E, Freeburn RW, Wheadon H. Patterns of Wnt/Fzd/ LRP gene expression during embryonic hematopoiesis. Stem Cells Dev. 2009;18:759-772. doi: 10.1089/scd.2008.0270.
46. Yao Y, Jumabay M, Ly A, Radparvar M, Cubberly MR, Boström KI. A role for the endothelium in vascular calcification. Circ Res. 2013;113:495-504. doi: 10.1161/CIRCRESAHA.113.301792.
47. Douillet CD, Velarde V, Christopher JT, Mayfield RK, Trojanowska ME, Jaffa AA. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am J Physiol Heart Circ Physiol. 2000;279:H2829-H2837.
48. Ruiz-Ortega M, Rodríguez-Vita J, Sanchez-Lopez E, Carvajal G, Egido J. TGF-beta signaling in vascular fibrosis. Cardiovasc Res. 2007;74:196-206. doi: 10.1016/j.cardiores.2007.02.008.